Acteoside significantly attenuated Parkinsonism symptoms by inhibiting rotenone-induced α-synuclein and caspase-3 upregulation, and microtubule-associated protein 2 downregulation in PD rats [108]. Here, MAP2 is linked to Parkinson disease.